Introduction
1st Golden HelixPharmacogenomics Day
Auditorium, Biomedical Research Foundation of the Academy of Athens
7 May 2009. Athens, GREECE
The 1st Golden Helix Pharmacogenomics day was held in the lecture hall of the Biomedical Research Foundation of the Academy of Athens. Over 100 participants followed this educational event that revolved around the promise of pharmacogenomics in modern medical practice, novel technologies pertaining to biomarker detection and applications of pharmacogenomics in the field of cardiovascular diseases and hemoglobinopathies.
Organized by:
Speakers
Organizing Committee
George P. Patrinos; Assistant Professor, University of Patras Department of Pharmacy, Patras, Greece
Despina Sanoudou; Researcher C', Biomedical Research Foundation of the Academy of Athens, Greece
Invited speakers
Sotiria Boukouvala (Alexandroupoli, Greece)
Theodoros Christopoulos (Patras, Greece)
Achilleas Gravanis (Crete, Greece)
Panagoula Kollia (Athens, Greece)
Kiriakos Kypreos (Patras, Greece)
George P. Patrinos (Patras, Greece)
Despina Sanoudou (Athens, Greece)
Scientific Program
Scientific Program
Session 1
13:00-13:20: Despina Sanoudou; Researcher C', Biomedical Research Foundation of the Academy of Athens, Greece
From Pharmacology and Genomics to Pharmacogenomics
13:20-13:50: Acchileas Gravanis; Professor, Unviersity of Crete School of Medicine, Heraklion, Greece
Pharmacogenomics in Clinical Practice: New technologies, economic and ethical implications
13:50-14:20: Theodoros Christopoulos, Professor, University of Patras Department of Chemistry, Patras, Greece
DNA biosensors in pharmacogenetic testing
14:20-14:40: Sotiria Boukouvala; Lecturer, Democritus University of Thrace, Department of Molecular Biology and Genetics, Alexandroupolis, Greece
From genes to drugs: The role of pharmacogenomics in the development of safer and more effective new treatments
COFFEE BREAK
Session 2
15:00-15:20: George P. Patrinos; Assistant Professor, University of Patras Department of Pharmacy, Patras, Greece
Pharmacogenomics and hemoglobinopathies
15:20-15:40: Kiriakos Kypreos; Associate Professor, Unviersity of Patras School of Medicine, Patras, Greece
Identification of new therapeutic targets for the development of new therapeutic interventions for metabolic syndrome
15:40-16:00: Panagoula Kollia; Assistant Professor, University of Athens, Department of Biology, Athens, Greece
Personalized Medicine: Ethical challenges
16:00-16:15: Concluding remarks
